Johanne U Hermansen

5PUBLICATIONS
21CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targetsPredictive and prognostic markersCancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jul 23, 2025
Proteasome inhibition overcomes resistance to targeted therapies in B-cell malignancy models and in an index patient.

Johanne U Hermansen, Paschalis Athanasiadis, Yanping Yin

|Jan 25, 2025
Longitudinal omics data and preclinical treatment suggest the proteasome inhibitor carfilzomib as therapy for ibrutinib-resistant CLL.

Lavinia Arseni, Gianluca Sigismondo, Haniyeh Yazdanparast

|Dec 01, 2023
Standardized assays to monitor drug sensitivity in hematologic cancers.

Pilar Ayuda-Durán, Johanne U Hermansen, Mariaserena Giliberto

|Sep 20, 2021
The Norwegian childhood cancer biobank.

Johanne U Hermansen, Dorota M Wojcik, Nina Robinson

Pageof 1